Surgical Treatment of Presbyopia – Challenges and Opportunities
Requesting many highly sought after answers to questions surrounding the surgical treatment of Presbyopia, co-moderators Dick Lindstrom, Founder and Attending Surgeon for Minnesota Eye Consultants and Eugene de Juan, Jr., MD, Founder & Vice-Chairman for ForSight Labs, dig into the underlying challenges and emerging possibilities in Presbyopia surgery. Lending their expertise to provide attendees with a comprehensive outlook, panelists Eric D. Donnenfeld, MD, FAAO, FACS, President Elect for ASCRS, David Chang, MD, President for ASCRS and Barry Cheskin, President & CEO and Co-Founder for PowerVision, Inc., deliver responses based on their real-time results and data.
Moderators:
Richard Lindstrom, MD
Dr Richard L Lindstrom, Founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinical Professor Emeritus at the University of Minnesota Department of Ophthalmology, Associate Director: Minnesota Lions Eye Bank, Board Member: University of Minnesota Foundation, and Visiting Professor: UC Irvine: Gavin Herbert Eye Institute.
Eugene de Juan, MD
Renowned retinal surgeon, inventor and entrepreneur Dr. Eugene de Juan, Jr., serves as Vice-Chairman of ForSight Labs, where he participates as an active inventor and advisor in early-stage ophthalmic device opportunities.
Panelists:
Barry Cheskin
Barry Cheskin is Co-Founder, President & CEO of PowerVision. Mr. Cheskin has over 20 years of general management experience in the medical device business.
Eric Donnenfeld, MD
Dr. Donnenfeld is a Clinical Professor of Ophthalmology at NYU, Trustee of Dartmouth Medical School, and founding partner of Ophthalmic Consultants of Long Island.
David Chang, MD
David F. Chang, MD is a graduate of Harvard College and Medical School, and completed his residency at UCSF where he is now clinical professor. He has been on the ASCRS Executive Committee since 2009, is a past president, and currently co-chairs the ASCRS Foundation.